China-based Hantech Medical Device Co., Ltd, a Contract Development Manufacturing Organization (CDMO) specializing in medical consumables, has announced the buyout of Becton, Dickinson and Company’s (BD) factory located in Villamarzana, Italy. This acquisition includes all assets such as land, factory buildings, and equipment. Concurrently, the US major has reached an agreement with Hantech Med to continue purchasing products and services from the factory.
Villamarzana Factory Overview and Hantech Med’s Expansion Plans
Established in 1973, the Villamarzana factory employs a workforce of 125 staff members and covers a floor space of 49,389 square meters. With this strategic acquisition, Hantech Med is poised to increase its manufacturing capacities by 45% by the second quarter of 2025. The company has set an ambitious target for annual income, expecting to earn at least USD 18.43 million in the next year.
Strategic Implications of the Acquisition
The acquisition of the Villamarzana factory not only expands Hantech Med’s global footprint but also aligns with its goal to enhance manufacturing capabilities. The continued partnership with Becton, Dickinson and Company for product and service purchases ensures business continuity and strengthens the factory’s position in the medical consumables market.-Fineline Info & Tech
